OBJECTIVES: To determine predictors of mortality in children on anti-retroviral therapy (ART) who attended the Paediatric HIV Clinic at Kamuzu Central Hospital in Lilongwe, Malawi. METHODS: Retrospective case cohort study by chart review of children who had started ART between October 2004 and May 2006. Bivariable and multivariable analysis were performed with and without defaulters to evaluate associations according to vital status and to identify independent predictors of mortality. RESULTS: Forty-one of 258 children (15.9%) were deceased, 185 (71.7%) were alive, and 32 (12.4%) had defaulted: 51% were female, 7% were under 18 months, 26% were 18 months to 5 years, and 54% were >5 years of age. Most were WHO stage III or IV (56% and 37%, respectively). On multivariate analysis, factors most strongly associated with mortality and defaulting were age <18 months [hazards ratio (HR) 2.11 (95% CI 1.0-4.51)] and WHO stage IV [HR 2.00 (95% CI 1.07-3.76)]. CONCLUSIONS: To improve outcomes of HIV-positive children, they must be identified and treated early, specifically children under 18 months of age. Access to infant diagnostic procedures must be improved to allow effective initiation of ART in infants at higher risk of death.
OBJECTIVES: To determine predictors of mortality in children on anti-retroviral therapy (ART) who attended the Paediatric HIV Clinic at Kamuzu Central Hospital in Lilongwe, Malawi. METHODS: Retrospective case cohort study by chart review of children who had started ART between October 2004 and May 2006. Bivariable and multivariable analysis were performed with and without defaulters to evaluate associations according to vital status and to identify independent predictors of mortality. RESULTS: Forty-one of 258 children (15.9%) were deceased, 185 (71.7%) were alive, and 32 (12.4%) had defaulted: 51% were female, 7% were under 18 months, 26% were 18 months to 5 years, and 54% were >5 years of age. Most were WHO stage III or IV (56% and 37%, respectively). On multivariate analysis, factors most strongly associated with mortality and defaulting were age <18 months [hazards ratio (HR) 2.11 (95% CI 1.0-4.51)] and WHO stage IV [HR 2.00 (95% CI 1.07-3.76)]. CONCLUSIONS: To improve outcomes of HIV-positive children, they must be identified and treated early, specifically children under 18 months of age. Access to infant diagnostic procedures must be improved to allow effective initiation of ART in infants at higher risk of death.
Authors: Salvador Resino; Rosa Resino; José Maria Bellón; Dariela Micheloud; Maria Dolores Gurbindo Gutiérrez; Maria Isabel de José; José Tomás Ramos; Pablo Martín Fontelos; Luis Ciria; Maria Angeles Muñoz-Fernández Journal: Clin Infect Dis Date: 2006-06-09 Impact factor: 9.079
Authors: Simon Makombe; Edwin Libamba; Eustice Mhango; Olga de Ascurra Teck; John Aberle-Grasse; Mindy Hochgesang; Erik J Schouten; Anthony D Harries Journal: Trans R Soc Trop Med Hyg Date: 2006-01-26 Impact factor: 2.184
Authors: Heena Brahmbhatt; Godfrey Kigozi; Fred Wabwire-Mangen; David Serwadda; Tom Lutalo; Fred Nalugoda; Nelson Sewankambo; Mohamed Kiduggavu; Maria Wawer; Ronald Gray Journal: J Acquir Immune Defic Syndr Date: 2006-04-01 Impact factor: 3.731
Authors: A Mocroft; S Vella; T L Benfield; A Chiesi; V Miller; P Gargalianos; A d'Arminio Monforte; I Yust; J N Bruun; A N Phillips; J D Lundgren Journal: Lancet Date: 1998-11-28 Impact factor: 79.321
Authors: Julius N Ngu; Douglas C Heimburger; Donna K Arnett; Christopher K Nyirenda; Dara Potter; Isaac Zulu; Claire N Bosire; Shashwatee Bagchi; Jiatao Ye; Benjamin H Chi; Edmond K Kabagambe Journal: N Am J Med Sci (Boston) Date: 2010
Authors: Mireille Porter; Mary-Ann Davies; Muntanga K Mapani; Helena Rabie; Sam Phiri; James Nuttall; Lee Fairlie; Karl-Günter Technau; Kathryn Stinson; Robin Wood; Maureen Wellington; Andreas D Haas; Janet Giddy; Frank Tanser; Brian Eley Journal: J Acquir Immune Defic Syndr Date: 2015-08-15 Impact factor: 3.731
Authors: Geoffrey A Preidis; Eric D McCollum; William Kamiyango; Alejandro Garbino; Mina C Hosseinipour; Peter N Kazembe; Gordon E Schutze; Mark W Kline Journal: J Acquir Immune Defic Syndr Date: 2013-05-01 Impact factor: 3.731
Authors: Nora M McCormick; Nan Li; David Sando; Aisa Muya; Karim P Manji; Rodrick Kisenge; Christopher Duggan; Guerino Chalamilla; Wafaie W Fawzi; Donna Spiegelman Journal: J Acquir Immune Defic Syndr Date: 2015-11-01 Impact factor: 3.731
Authors: Andrew Edmonds; Marcel Yotebieng; Jean Lusiama; Yori Matumona; Faustin Kitetele; Sonia Napravnik; Stephen R Cole; Annelies Van Rie; Frieda Behets Journal: PLoS Med Date: 2011-06-14 Impact factor: 11.069
Authors: Angela McLigeyo; Paul Wekesa; Kevin Owuor; Jonathan Mwangi; Linda Isavwa; Immaculate Mutisya Journal: AIDS Res Hum Retroviruses Date: 2022-03-30 Impact factor: 1.723